| 928659-17-0

• 物质功能分类: 原料药 - 人工合成抗感染类药 - 抗病毒类药
• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• CAS: 928659-17-0
• 化学式: C5H6N6NaO4S
• 分子量: 269.2
• InChiKey: XADHWMBJEDRDPD-UHFFFAOYSA-N

物化性质

• 溶解度：
  二甲基亚砜：125 mg/mL（436.76 mM）

安全信息

• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

制备方法与用途

生物活性

Triazavirin (TZV, Riamilovir)是一种新型的抗病毒药物，一种核酸的 nucleoside analogue，可抑制 synthesis of viral RNA and DNA 以及基因组片段的复制。Triazavirin 对流感和许多其他病毒具有活性。Triazavirin 在流感传播阶段可作为有效的保护性药剂。

靶点

Nucleoside analogue; Influenza virus

体外研究

The efficacy of Triazavirin against the tick-borne encephalitis virus is estimated in the sensitive cell culture. In a concentration of 128 mcg/mL Triazavirin is shown active in inhibition of the tick-borne encephalitis virus reproduction (strain Sofiin ) by accumulation in the SKEV cell culture.

体内研究

The therapeutic efficacy Triazavirin against experimental Forest-Spring encephalitis on albino mice is studied. The results shows that in high doses (200-400 mg/kg) Triazavirin moderately protects the infected animals. A significant increase of the animal lifespan in the test groups (from 4.1 to 4.8 days) and a statistically valid decrease of the virus accumulation in the target organ are observed.